期刊文献+

人表皮生长因子受体胞内酪氨酸激酶结构域原核表达

Prokaryotic Expression of the Intracellular Tyrosine Kinase Domain of Human Epidermal Growth Factor Receptor
下载PDF
导出
摘要 目的研究人表皮生长因子受体(EGFR)胞内酪氨酸激酶结构域的原核表达及纯化条件。方法构建原核表达人EGFR胞内酪氨酸激酶结构域的重组质粒pGEX/GST-EGFR-TKD,在大肠杆菌中表达目的融合蛋白,通过在尿素中变性、在梯度尿素中透析复性,经GST融合蛋白纯化,肠激酶去除GST“标签”后获得人EGFR胞内酪氨酸激酶结构域蛋白。结果限制酶切分析和测序表明成功构建重组质粒pGEX/GST-EGFR-TKD;SDS-PAGE分析表明,异丙基硫代-β-D半乳糖苷诱导下可以表达融合蛋白GST-EGFR-TKD,但以不溶性包涵体的形式存在。经尿素变性、梯度透析复性及去除GST“标签”后,获得重折叠的人EGFR胞内酪氨酸激酶结构域蛋白。结论在大肠杆菌中可成功表达人EGFR胞内酪氨酸激酶结构域蛋白。 Objective To investigate the prokaryotie expression of the intraeellular tyrosine kinase domain of human epidermal growth factor receptor(EGFR) and the purification conditions. Methods Recombinant plasmid pGEX/GST-EGFR-TKD which contain human EGFR intracellular tyrosine kinase domain is constructed. The fusion protein was expressed in E. coli and then denatured by urea solution, and renewal with dialysis in gradient urea solution and purified. Enterokinase was added to remove GST- tag to get human EGFR-TKD. Results Recombinant plasmid pGEX/GST-EGFR-TKD was successfully constructed and confirmed by enzyme restriction and sequencing. SDS-PAGE identified fusion protein GST-EGFR-TKD was expressed under induction of IPTG in form of insoluble inclusion body. After denaturing in urea, gradient dialysis and cleavage of GST-tag, refolded human EGFR-TKD was obtained. Conclusion Human EGFR-TKD can be expressed in E. coll.
出处 《福建医科大学学报》 2006年第3期211-214,共4页 Journal of Fujian Medical University
基金 国家留学基金资助项目 福建省自然科学基金资助项目(C0540009)
关键词 表皮生长因子受体蛋白质酪氨基酸激酶 基因表达 原核细胞 谷胱甘肽转移酶 质粒 大肠杆菌 epidermal growth factor receptor protein-tyrosine kinase gene expression prokaryotic cells glutathione transferase plasmids escherichia coli
  • 相关文献

参考文献11

  • 1Ciardiello F. Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents[J]. Drugs, 2000,60(Suppl 1):25-32.
  • 2Ciardiello F,Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor [J].Clin Cancer Res, 2001,7:2958-2970.
  • 3Salomon DS, Brant R, Ciardiello F, et al. Epidermal growth factor-related peptides and their receptors in human malignancies[J]. Crit Rev Oncol Hematol , 1995,19 : 183-232.
  • 4Woodburn JR. The epidermal growth factor receptor and its inhibition in cancer therapy[J]. Pharmacol Ther, 1999,82:241-251.
  • 5Yarden Y, Sliwkowski MX. Untangling the ErbB signaling network[J]. Nat Rev Mol Cell Biol, 2001,2 : 127-137.
  • 6Klapper LN, Kirschbaum MH, Sela M, et al. Biochemical and clinical implication of the ErbB/HER signaling network of growth factor receptors[J]. Adv Cancer Res, 2000,77:25-79.
  • 7Ranson M. Epidermal growth factor receptor tyrosine kinase inhibitors[J]. Br J Cancer, 2004,14:2250-2255.
  • 8Dancey JE. Predictive factors for epidermal growth factor receptor inhibitors-the bull's-eye hits the arrow[J]. Cancer Cell,2004,5:411-425.
  • 9Ausubel FM,Brent R, Kingston RE, et al. Current protocols in molecular biology[M]. Volume 3. Net York:John Willey Sons Press, 1994:16.7.1-16.7.7.
  • 10Maya S, Yaron M,Ami C, et al. Polar expression of ErbB-2/HER2 in epithelia: bimodal regulation by Lin-7[J]. Developmental Cell, 2003,5 : 475-486.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部